About EBNESINA journal
The EBNESINA journal is an international, multidisciplinary, peer-reviewed, open-access journal, a peer-reviewed, open-access, quarterly journal in Persian (with extended English abstracts and bibliographies) dedicated to the fields of military medicine, disaster medicine, military psychiatry, aerospace medicine, and subaquatic medicine, published by Iran Air Force health administration and is scientifically sponsored by the Aja University of Medical Sciences. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering the research ethics and academic rules and regulations.
   The EBNESINA journal is committed to publishing cutting-edge, innovative, original, and timely research on military medicine, disaster medicine, military psychiatry, aerospace medicine, and subaquatic medicine. Authors are encouraged to submit original research and review manuscripts that are not under consideration for publication elsewhere to the journal for review. All manuscripts undergo peer review to determine their originality, validity, significance, and scientific value. Submitted manuscripts are peer reviewed by members of the Editorial Board or other experts chosen by the Editor. The Editor-in-Chief of the journal is responsible for final editing, decisions regarding acceptance, revisions, and rejection. Submission of a manuscript to the journal is taken as evidence that no portion of the text, tables, or figures has been copyrighted, published, or submitted for publication elsewhere, unless information regarding previous publication is cited and permission obtained. A copy of any such permission obtained must accompany the manuscript.
    All manuscripts undergo a double-blind peer-review process. The submitted manuscripts will be published after a thorough review and the editorial board's approval. Researchers are highly encouraged to visit the website, register, submit, and prepare their manuscripts according to the Instructions to the Authors. Therefore, visiting in person or calling the journal office is not recommended; all communication with authors and reviewers should be conducted through the website.


Highlights of the Journal
- Authors' emails are answered within 48 hours.
- The journal has a famous editorial board.
- The journal is committed to the highest standards of double-blind peer-review.
- Accepted articles will be published as open access very soon.
- The author will receive a notification of acceptance or rejection within 4-6 months of submitting the article.
- All authors receive a copy of the certificate and acceptance letter of the article.
- The journal has a good number of readers and is one of the top journals in its field.
- The journal is indexed in international and national databases.
- All accepted articles can be viewed, downloaded, and printed in PDF format.
- The journal has a high citation rate and research impact rate in the Islamic World Science Citation Database (ISC).
- The journal has organizational support and a complete archive of articles.
 

	Chairman: Dr. Seyed Zia Hejripour Rafsanjani Editor in Chief: Dr. Arsia Taghva Associate Editor: Dr. Reza Eslami Executive Manager: Dr. Kamyab Alizadeh
Subject Area and Category	Subject Area and Category based on Scopus: Medicine      - Medicine (miscellaneous)      - Public Health, Environmental and Occupational Health      - Emergency Medicine      - Psychiatry and Mental Health      - Sports Medicine
Coverage Scope	Topic MeSH Descriptors UNESCO/Other Thesauri Military Medicine "Military Medicine", "Combat Disorders" "Armed forces", "Health services" Disaster Medicine "Disaster Medicine", "Disasters" "Disasters", "Emergency services" Military Psychiatry "Military Psychiatry", "PTSD" "Mental health", "Armed conflicts" Aerospace Medicine "Aerospace Medicine", "Space Flight" "Aeronautics", "Space sciences" Subaquatic Medicine "Diving", "Hyperbaric Oxygenation" "Diving", "Oxygen therapy"
Language	Persian; including extended English abstracts and bibliographies.
Start Year	2006
Frequency	Quarterly
Publishing Schedule	March, June, September, and December
Place of Publication	Iran, Tehran
Publisher	Iran Air Force health administration
Scientific Sponsorship Society	Aja University of Medical Sciences
Status	Active
Refereed	Yes
Peer Review Type	Double Blind Peer Review
Primary Review Time	10 days, approximately
Acceptance and Publication Time	12 weeks
Manuscript Acceptance Rate	20%
Reference Style	The Vancouver citation style
ORCID iDs	The ORCID identifier is required.
Type of Material	Serial (Periodical)
Description	The EBNESINA journal is an international, multidisciplinary, peer-reviewed, open-access journal, a peer-reviewed, open-access, quarterly journal in Persian (with extended English abstracts and bibliographies) dedicated to the fields of military medicine, disaster medicine, military psychiatry, aerospace medicine, and subaquatic medicine, published by Iran Air Force health administration and is scientifically sponsored by the Aja University of Medical Sciences. It is an interdisciplinary journal devoted to the publication of original articles, review articles, etc., considering the research ethics and academic rules and regulations.
Type of Access	Open Access (OA)
OA Policies	The journal adheres to DOAJ's definition of open access.
Type of License	Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Open Access Statement	EBNESINA journal is a fully open-access journal, which means that all articles are available on the Web to all users immediately upon publication. All content of the Journal is published with open access under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). This license allows users to copy and redistribute the article under the following conditions: Share — copy and redistribute the material in any medium or format; Adapt — remix, transform, and build upon the material. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes.   Benefits of open access for authors include:    - Authors retain copyright to their work.    - Free access for all users worldwide.    - Increased visibility and readership.    - No spatial constraints.    - Rapid publication.
The Policy of Screening for Plagiarism	We accept all terms and conditions of COPE regarding plagiarism in a submitted manuscript, and in case any attempt of plagiarism is brought to our attention accompanied by convincing evidence, we act based on flowcharts and workflows determined in COPE.     All manuscripts must be free of any form of plagiarism. Manuscripts submitted to the EBNESINA journal will be screened for plagiarism using similarity check and plagiarism detection tools. All authors are advised to use plagiarism detection software to check the similarity before submitting their manuscript to the journal. Editors check the plagiarism detection of manuscripts in the EBNESINA journal using the Grammarly detection software (www.grammarly.com), and iThenticate (www.ithenticate.com) for English abstracts and use Iranian plagiarism detection software such as IranDOC (https://tik.irandoc.ac.ir) and Samimonour (www.samimnoor.ir) for the Persian text. The journal will immediately reject papers leading to plagiarism or self-plagiarism. Whenever it is determined that the manuscript has not complied with the plagiarism rules, it will be REJECTED (before acceptance for publication), and if it was published, it will be RETRACTED for plagiarism issues. The EBNESINA journal aims to ensure that all authors are careful and comply with international standards for academic integrity, particularly on the issue of plagiarism. Plagiarism occurs when an author takes ideas, information, phrases, or words from another source without proper credit to the source. Even when it occurs unintentionally, plagiarism is still a serious ethical violation and unacceptable in scientific academic publications. When the author takes an idea from another author, a citation is required even if the author then develops the idea further. This might be an idea about how to interpret the data, either what methodology to use or what conclusion to draw. It might be an idea about broad developments in a field or general information. Regardless of the idea, authors should cite their information sources. In cases where the author develops the idea further, it is still necessary to cite the original source of the idea, and then in a subsequent sentence, the author can explain his or her more developed idea. When the author takes words from another author, a citation and quotation marks are required. Whenever four or more consecutive words are identical to a source that the author has read, the author must use quotation marks to denote the use of another author's original words; just a citation is no longer enough.
Retraction Policy	An article may be retracted when its findings are no longer considered trustworthy due to scientific misconduct or error, it plagiarizes previously published work, or it is found to violate ethical guidelines. An article may be retracted when the integrity of the published work is substantially undermined owing to errors in the conduct, analysis, and/or reporting of the research. Violation of publication or research ethics may also result in a study’s retraction. The original paper will be marked as RETRACTED, but a PDF version remains available to readers, and the RETRACTION statement is bi-directionally linked to the original published paper. Retraction statements will typically include a statement of assent or dissent from the authors.
Type of Publication (Processing Charges and Publication Charges)	No Article Publication Charges (APCs) are required from the author(s). Full-text access: Open Access
Authorship	The consent of all authors, as well as related authorities/institutions, has been received prior to the submission of the manuscript. The order of the authors (as to be reflected in the published article) has been established. The addition or deletion of authors once the manuscript has been accepted for publication would have to be accompanied by a signed statement of consent from all authors. All authors have contributed significantly to the research. Authors are obligated to participate in the peer review process, providing retractions/corrections/amendments when necessary. All conflicts of interest/financial support have been declared. Any changes or corrections to a published work require the consent of all authors.
Copyright owner / Copyright holder	Authors retain unrestricted copyrights and publishing rights. The author has complete control over the work (e.g., retains the right to reuse, distribute, republish, etc.).
Copyright Notice	Authors who publish in this journal agree to the following terms: 1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0), which allows others to: Share — copy and redistribute the material in any medium or format; Adapt — remix, transform, and build upon the material. The licensor cannot revoke these freedoms as long as you follow the license terms. Under the following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. NonCommercial — You may not use the material for commercial purposes.   2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal. 3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See: The Effect of Open Access).
Revenue Sources	Organizational and institutional support, Donations
COPE	EBNESINA journal follows the policies and guidelines of the Committee on Publication Ethics (COPE) and abides by its Code of Conduct in dealing with potential cases of misconduct.
Complaint Process	The authors have the right to complain and ask for an explanation if they perceive any misconduct in any applicable policies and ethical guidelines. The authors can raise their complaints by submitting a letter to: ebnesinajournalyahoo.com. We follow the COPE guidelines on responding to whistleblowers, which include protecting anonymity. All the complaints regarding delinquencies in the work processes are investigated according to the prevailing publication ethics practices. An author or any other scholar may submit their complaints about any issues related to: - Authorship issues; - Bias in the review process; - Copyright violation; - Deceiving in research results or wrong research results; - Manuscript processing time is unusually late; - Plagiarism; - The peer-review comments are unsatisfactory; - Unrevealed conflicts of interest; and   - Violations of research ethics and integrity.
Policy for Dealing with Complaints	Once a complaint is received, at first, an acknowledgment is sent to the complainant with the assurance that appropriate action will be taken on a complaint within three working days, excluding the complaint receiving date. The investigation process is initiated by the journal handling team according to the directions of the Editor-In-Chief. After the investigation is over, a meeting is held with a complete report on the complaint. The decision has been made and the same is forwarded to the concerned scholar through his/her submitted email ID. We consider complaints as an opportunity to enhance our existing Manuscript Processing System. All the received complaints are dealt with in a polite and timely manner with certainty.
Digital Archiving Policy	EBNESINA journal works with some organizations such as the Islamic World Science Citation Database (ISC), the Iran National Library and Archives, and the server of the Aja University of Medical Sciences to maintain the digital archive. This makes possible the permanent availability and preservation of scholarly research and ensures accessibility by converting and upgrading digital file formats to comply with new technology standards.
I4OC Standards for Open Citations	Yes. The journal complies with I4OC standards for open citations.
Data Citation	Data should be cited in the same way as articles, books, and web citations, and authors are required to include data citations as part of their reference list. Data citation is appropriate for data held within institutional, subject-focused, or more general data repositories. It is not intended to take the place of community standards such as in-line citation of GenBank accession codes. When citing or making claims based on data, authors must refer to the data at the relevant place in the manuscript text and also provide a formal citation in the reference list. EBNESINA journal follows the format proposed by the Joint Declaration of Data Citation Principles: Authors; Year; Dataset title; Data repository or archive; Version (if any); Persistent identifier (e.g. DOI)”.
Data Sharing Policy	EBNESINA journal uses the Basic Data Sharing Policy. The journal is committed to a more open research landscape, facilitating faster and more effective research discovery by enabling reproducibility and verification of data, methodology, and reporting standards. The EBNESINA journal encourages authors to cite and share their research data including, but not limited to: raw data, processed data, software, algorithms, protocols, methods, and materials. Authors are encouraged to share the data supporting the results or analyses presented in their article where this does not violate the protection of human subjects or other valid privacy or security concerns.    EBNESINA journal encourages authors to share the data and other artifacts supporting the results in the article by archiving it in an appropriate public repository. Authors should include a Data Accessibility Statement, including a link to the repository they have used, so that this statement can be published alongside their paper.    EBNESINA journal requires authors of Original Investigation, and Special Paper articles to (1) place the de-identified data associated with the manuscript in a repository, and (2) include a Data Availability Statement in the manuscript describing where and how the data can be accessed.    EBNESINA journal defines data as the digital materials underlying the results described in the manuscript, including but not limited to spreadsheets, text files, interview recordings or transcripts, images, videos, output from statistical software, and computer code or scripts. Authors are expected to deposit at least the minimum amount of data needed to reproduce the results described in the manuscript.    Data can be placed in any repository that makes data publicly available, providing a unique persistent identifier, including institutional repositories, general repositories (e.g., Figshare, Open Science Framework, Zenodo, Dryad, Harvard Dataverse, OpenICPSR), or discipline-specific repositories. The Data Availability Statement should be placed in the manuscript at the end of the main text before the references. This statement must include (1) an indication of the location of the data; (2) a unique identifier, such as a digital object identifier (DOI), accession number, or persistent uniform resource locator (URL); and (3) any instructions for accessing the data, if applicable. At the point of submission, you will be asked if there is a data set associated with the paper. If you reply yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared to share the reviewer URL associated with your data deposit, upon request by reviewers. Where one or multiple data sets are associated with a manuscript, these are not formally peer-reviewed as a part of the journal submission process. It is the author’s responsibility to ensure the soundness of the data. Any errors in the data rest solely with the producers of the data set(s). Please note: As you are submitting your manuscript to the EBNESINA journal where submissions are double-blind peer-reviewed, the main text file should not include any information that might identify the authors (i.e., Author Name, Address, Conflict of Interest, and fund-related information). As a data availability statement could reveal your identity, we recommend removing this from the anonymized version of the manuscript.     Exceptions to this policy will be made in rare cases in which de-identified data cannot be shared due to their proprietary nature or participant privacy concerns. Exceptions to policy and restrictions on data availability are granted for reasons associated with the protection of human privacy, issues such as biosafety, and/or to respect terms of use for data obtained under license from third parties. Confidential data, e.g., human subjects or patient data, should always be anonymized, or permission to share should be obtained in advance. If in doubt, authors should seek counsel from their institution’s ethics committee. Authors should include a data accessibility statement, including a link to the repository they have used so that this statement can be published alongside their paper. Below are some examples. Data Availability Statement: 1. Data associated with this article are available in the Open Science Framework at . 2. The data that support the findings of this study are openly available in [repository name] at http://doi.org/[doi], reference number [reference number]. 3. The data that support the findings of this study are openly available in [repository name] at [URL], reference number [reference number]. 4. The data that support the findings of this study are available in [repository name] at [URL/DOI], reference number [reference number]. These data were derived from the following resources available in the public domain: [list resources and URLs]
Informed Consent	All participants in human subjects' articles have a right to privacy that should not be violated without informed consent. Identifying information, including names, initials, etc., should not be published in written descriptions, photographs, or pedigrees unless the information is essential for scientific purposes and the participants (or parent or guardian) give written informed consent for publication. Informed consent in this situation requires that an identifiable participant be shown the manuscript, providing consent before publication. Authors should disclose to these patients whether any potential identifiable material might be available via the Internet as well as in print after publication. Participants' consent should be written and archived either with the EBNESINA journal, the authors, or both, as dictated by local regulations or laws.
Declaration of generative AI in scientific writing	Where authors use generative artificial intelligence (AI) and AI-assisted technologies in the writing process, they should only employ these technologies to improve readability and language. The application of AI technology must be accompanied by human oversight and control. Authors should carefully review and edit the results because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. AI and AI-assisted technologies should not be listed as authors or co-authors, nor should they be cited as an author.  Authorship implies tasks and responsibilities that are uniquely attributed to and performed by humans. Authors should disclose their use of AI and AI-assisted technologies in the writing process by following the instructions provided. A statement acknowledging this use will appear in the published article. It is essential to recognize that authors remain ultimately responsible and accountable for the content of their articles. Disclosure instructions: Authors should disclose in their manuscript the use of generative AI and AI-assisted technologies in the writing process by adding a statement at the end of their manuscript in the core manuscript file, before the References list. The statement should be placed in a new section entitled ‘Declaration of Generative AI and AI-assisted technologies in the writing process’. Statement: During the preparation of this work the author(s) used [NAME TOOL / SERVICE] in order to [REASON]. After using this tool/service, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication. This declaration does not apply to the use of basic tools for checking grammar, spelling, references, etc. If there is nothing to disclose, there is no need to add a statement.
Privacy Statement	The names and e-mail addresses entered in this journal website will be used exclusively for the stated purposes of this journal and will not be made available for any other purposes or to any other parties.
Advertising Policy	The EBNESINA journal maintains a strict policy of academic and scientific integrity and independence. As such, the journal does not accept or display any form of advertising—whether print, digital, or promotional content—from commercial entities, pharmaceutical companies, or any third-party organizations. This policy ensures that all content published in the journal remains free from commercial influence and is evaluated solely on the basis of academic merit, scientific validity, and relevance to the journal’s scope. The absence of advertising also supports the transparency and credibility of the research we publish. By maintaining this clear separation between editorial content and commercial interests, the EBNESINA journal upholds the highest standards of scholarly publishing and protects the trust of authors, readers, and the broader scientific community.
Address	Office of " EBNESINA journal ", IRIAF Health Administration Deputy of Research and Education, Be'sat Hospital, Basidj Highway, Tehran, Iran. P.O. Box: 11151/17819
Tel.	(+98)-21-39954937
Telefax	(+98)-21-39954960
E-mail	ebnesinajournalyahoo.com
Gmail	ebnesina.ajaums.ac.irgmail.com
URL	https://ebnesina.ajaums.ac.ir